EdgeMarketInstruments › NXTS

NXTS — Nexentis Technologies Inc.

US Healthcare Pharma & biotech equity mkt cap 2.6M
1.77 -1.67% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 1.48 · high 56.84

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-05-14.

Performance

1 day-1.67%
1 week-7.33%
1 month-7.33%
3 months-59.95%
6 months-72.81%
Year to date-84.10%
1 year-96.44%
3 years-99.85%
5 years-99.99%

Technicals

RSI 1431.9
vs 50-day avg-45.72%
vs 200-day avg-78.47%
Volatility 1y203.9%
Max drawdown 1y-97.40%
Avg volume 30d74.0K
Daily bars held1,324
History from2021-05-14

Measured signals that fired on NXTS

datesignal measured base rate
2026-07-07Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-06-24Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group
2026-06-22Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-02-09Barda Lital
Chief Financial Officer
Grant or award50.0K0.000
2026-02-09Palach David
Chief Executive Officer
Grant or award100.0K0.000
2026-02-09Zakai Shlomo
Controller
Grant or award50.0K0.000
2026-02-09Weiss Amitay
Director
Grant or award116.3K0.000
2026-01-29Lee Eun Young
Open-market sale1271.36173
2025-05-12Barda Lital
Chief Financial Officer
Grant or award300.0K0.000
2025-05-12Palach David
Chief Executive Officer
Grant or award600.0K0.000
2024-12-23Sidi Liat
Director
Grant or award50.0K0.000
2024-12-23Weiss Amitay
Director
Grant or award350.0K0.000
2024-12-23Berenstein Israel Yakov
Director
Grant or award50.0K0.000

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
GEODE CAPITAL MANAGEMENT, LLC31.1K49.8K
XTX Topco Ltd14.4K21.8K
Yorkville Advisors Global, LP10.8K16.4K
UBS Group AG8.6K13.1K
VANGUARD FIDUCIARY TRUST CO4.6K7.0K
Tower Research Capital LLC (TRC)3.0K4.5K
SBI Securities Co., Ltd.3858
MORGAN STANLEY35
Caitong International Asset Management Co., Ltd11

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-132026-06-30on EDGAR ↗
8-K2026-08-062026-08-06on EDGAR ↗
EFFECT2026-07-17on EDGAR ↗
EFFECT2026-07-15on EDGAR ↗
SCHEDULE 13G/A2026-07-15on EDGAR ↗
S-12026-07-13on EDGAR ↗
POS AM2026-07-13on EDGAR ↗
424B52026-06-23on EDGAR ↗

Short selling

Avg short volume, 90d37.6% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about NXTS

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open NXTS in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →